RxDoctor Payments Data

Edward Booker, MD

Family Medicine · West Union, SCNPI 1386701563

Payments from drug & device makers

$7,146in general payments, 2019–2025

Across 474 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$573
  • Novo Nordisk$563
  • Amgen$472
  • Otsuka America Pharmaceutical, Inc.$457
  • AstraZeneca$374
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$7,146100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,146 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$142,309
Medicare patients
352
Services billed
2,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban150$108,683
JardianceEmpagliflozin120$101,417
JanuviaSitagliptin Phosphate54$62,199
MounjaroTirzepatide49$54,983
FarxigaDapagliflozin Propanediol79$53,399
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$50,583
TrulicityDulaglutide39$43,175
OzempicSemaglutide34$35,534
XareltoRivaroxaban40$31,048
RybelsusSemaglutide21$23,294
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$20,083
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$17,931
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen660$14,964
LinzessLinaclotide19$14,883
EntrestoSacubitril/Valsartan11$11,041

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$207$108,683150 claims
Boehringer IngelheimJardiance, Synjardy$54$107,751131 claims
Lilly USA, LLCMounjaro, Trulicity$573$98,15888 claims
AstraZenecaFarxiga, Breztri Aerosphere$374$73,482110 claims
MerckJanuvia, Belsomra$43$70,44370 claims
Novo NordiskOzempic, Rybelsus$563$58,82855 claims
GSKTrelegy Ellipta, Breo Ellipta$267$56,45683 claims
Johnson & JohnsonXarelto$139$31,04840 claims
AbbVieLinzess$1,194$14,88319 claims
NovartisEntresto$228$11,04111 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$191$10,38213 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$156$5,52712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in West Union

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →